Bausch Health Companies Inc. (TSX:BHC)
7.92
0.00 (0.00%)
Sep 18, 2026, 4:00 PM EST
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.85B USD in the quarter ending June 30, 2026, with 12.73% growth. This brings the company's revenue in the last twelve months to $12.20B, up 10.47% year-over-year. In the year 2025, Bausch Health Companies had annual revenue of $10.27B with 6.66% growth.
Revenue (ttm)
$12.20B
Revenue Growth
+10.47%
P/S Ratio
0.19
Revenue / Employee
$601.12K
Employees
20,300
Market Cap
2.97B CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.27B | 641.00M | 6.66% |
| Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
| Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
| Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
| Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
| Dec 31, 2018 | 8.38B | -344.00M | -3.94% |
| Dec 31, 2017 | 8.72B | -950.00M | -9.82% |
| Dec 31, 2016 | 9.67B | -773.00M | -7.40% |
| Dec 31, 2015 | 10.45B | 2.24B | 27.31% |
| Dec 31, 2014 | 8.21B | 2.44B | 42.23% |
| Dec 31, 2013 | 5.77B | 2.29B | 65.77% |
| Dec 31, 2012 | 3.48B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apotex Health | 3.20B |
| Green Thumb Industries | 1.72B |
| Verano Holdings | 1.19B |
| Cresco Labs | 924.67M |
| Vireo Growth | 726.62M |
| Knight Therapeutics | 547.31M |
| Canopy Growth | 293.63M |
| DRI Healthcare Trust | 285.04M |
Bausch Health Companies News
- 11 days ago - Bausch Health and YUN expand to Mexico and additional EMEA Markets - TheFly
- 11 days ago - Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets - PRNewsWire
- 18 days ago - Bausch Health announces availability of Solta Medical’s Fraxel FTX in Australia - TheFly
- 23 days ago - Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners - PRNewsWire
- 26 days ago - Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results - Business Wire
- 4 weeks ago - Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners - PRNewsWire
- 4 weeks ago - Bausch Health put volume heavy and directionally bearish - TheFly
- 6 weeks ago - Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - PRNewsWire